Evidence map›Paper›PMID 18047710›Full record

ArticleBMC bioinformatics2007

Preliminary nanopore cheminformatics analysis of aptamer-target binding strength.

Karen Thomson, Iftekhar Amin, Eric Morales, Stephen Winters-Hilt

Abstract read
In one paragraph

Article in BMC bioinformatics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Sensing with Nanopores and Aptamers: A Way Forward.Sensors (Basel, Switzerland) · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karen ThomsonDepartment of Computer Science, University of New Orleans, New Orleans, LA 70148, USA. kthomson@uno.edu
Iftekhar Amin
Eric Morales
Stephen Winters-Hilt

Funding

Nanopore study of single antibody-antigen interactionsK22LM008794 · NLM · CHILDREN'S HOSPITAL (NEW ORLEANS) · PI WINTERS-HILT, STEPHEN · 2005 to 2007
$486k
NLM NIH HHS 5K22LM008794NLM NIH HHS K22 LM008794
6 · The paper itself

Abstract

backgroundAptamers are nucleic acids selected for their ability to bind to molecules of interest and may provide the basis for a whole new class of medicines. If the aptamer is simply a dsDNA molecule with a ssDNA overhang (a "sticky" end) then the segment of ssDNA that complements that overhang provides a known binding target with binding strength adjustable according to length of overhang.

resultsTwo bifunctional aptamers are examined using a nanopore detector. They are chosen to provide sensitive, highly modulated, blockade signals with their captured ends, while their un-captured regions are designed to have binding moieties for complementary ssDNA targets. The bifunctional aptamers are duplex DNA on their channel-captured portion, and single-stranded DNA on their portion with binding ability. For short ssDNA, the binding is merely to the complementary strand of DNA, which is what is studied here - for 5-base and 6-base overhangs.

conclusionA preliminary statistical analysis using hidden Markov models (HMMs) indicates a clear change in the blockade pattern upon binding by the single captured aptamer. This is also consistent with the hypothesis that significant conformational changes occur during the annealing binding event. In further work the objective is to simply extend this ssDNA portion to be a well-studied approximately 80 base ssDNA aptamer, joined to the same bifunctional aptamer molecular platform.

Indexed as

AntibodiesAptamers, NucleotideBacterial ToxinsBiosensing TechniquesEquipment DesignEquipment Failure AnalysisHemolysin ProteinsImmunoassayNanotechnologyPilot ProjectsPorosityReproducibility of ResultsSensitivity and SpecificityTransducersAntibodiesAptamers, NucleotideBacterial ToxinsHemolysin Proteinsstaphylococcal alpha-toxin

Identifiers

PMID18047710
PMCPMC2099479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.